6.
Downward J
. RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?. Clin Cancer Res. 2015; 21(8):1802-9.
PMC: 4413026.
DOI: 10.1158/1078-0432.CCR-14-2180.
View
7.
Chang J, Chen C, Wu Y, Che T, Huang Y, Yeh K
. Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma. Oncotarget. 2016; 7(45):73664-73680.
PMC: 5342006.
DOI: 10.18632/oncotarget.12046.
View
8.
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L
. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019; 18(1):46.
PMC: 6437932.
DOI: 10.1186/s12943-019-1004-4.
View
9.
Blank J, Liu X, Cosmopoulos K, Bouck D, Garcia K, Bernard H
. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. Cancer Res. 2012; 73(1):225-34.
DOI: 10.1158/0008-5472.CAN-12-1729.
View
10.
Boone C, Bussey H, Andrews B
. Exploring genetic interactions and networks with yeast. Nat Rev Genet. 2007; 8(6):437-49.
DOI: 10.1038/nrg2085.
View
11.
Bartz S, Zhang Z, Burchard J, Imakura M, Martin M, Palmieri A
. Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol. 2006; 26(24):9377-86.
PMC: 1698535.
DOI: 10.1128/MCB.01229-06.
View
12.
Srihari S, Singla J, Wong L, Ragan M
. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer. Biol Direct. 2015; 10:57.
PMC: 4590705.
DOI: 10.1186/s13062-015-0086-1.
View
13.
Wu M, Li X, Zhang F, Li X, Kwoh C, Zheng J
. In silico prediction of synthetic lethality by meta-analysis of genetic interactions, functions, and pathways in yeast and human cancer. Cancer Inform. 2014; 13(Suppl 3):71-80.
PMC: 4224103.
DOI: 10.4137/CIN.S14026.
View
14.
Huang J, Wu M, Lu F, Ou-Yang L, Zhu Z
. Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization. BMC Bioinformatics. 2019; 20(Suppl 19):657.
PMC: 6929405.
DOI: 10.1186/s12859-019-3197-3.
View
15.
Barabasi A, Gulbahce N, Loscalzo J
. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2010; 12(1):56-68.
PMC: 3140052.
DOI: 10.1038/nrg2918.
View
16.
Iglehart J, Silver D
. Synthetic lethality--a new direction in cancer-drug development. N Engl J Med. 2009; 361(2):189-91.
DOI: 10.1056/NEJMe0903044.
View
17.
Qi Y, Suhail Y, Lin Y, Boeke J, Bader J
. Finding friends and enemies in an enemies-only network: a graph diffusion kernel for predicting novel genetic interactions and co-complex membership from yeast genetic interactions. Genome Res. 2008; 18(12):1991-2004.
PMC: 2593582.
DOI: 10.1101/gr.077693.108.
View
18.
Liany H, Jeyasekharan A, Rajan V
. Predicting synthetic lethal interactions using heterogeneous data sources. Bioinformatics. 2019; 36(7):2209-2216.
DOI: 10.1093/bioinformatics/btz893.
View
19.
Wong S, Zhang L, Tong A, Li Z, Goldberg D, King O
. Combining biological networks to predict genetic interactions. Proc Natl Acad Sci U S A. 2004; 101(44):15682-7.
PMC: 524818.
DOI: 10.1073/pnas.0406614101.
View
20.
Wang S, Xu F, Li Y, Wang J, Zhang K, Liu Y
. KG4SL: knowledge graph neural network for synthetic lethality prediction in human cancers. Bioinformatics. 2021; 37(Suppl_1):i418-i425.
PMC: 8336442.
DOI: 10.1093/bioinformatics/btab271.
View